In-Hospital Outcomes and Long-Term Follow-Up after Percutaneous Transcatheter Closure of Postinfarction Ventricular Septal Defects
Table 3
Individual characteristics regarding patients, procedures, complications, and in-hospital follow-up.
Patient number
Age
Sex
VSD location
VSD size (mm)
Device (mm)
Implantation successful
Complication
Survival
Follow-up duration (days)
1
58
F
Muscular
15
VSD 24
+
−
+
35
2
59
F
Muscular
9
VSD 16
+
−
+
108
3
64
M
Muscular
10 & 12
VSD 14 & 16
+
Residual shunting
+
114
4
54
F
Muscular
16
−
−
LV rupture during device implantation
−
0
5
67
F
Muscular
11
VSD 20
+
−
+
378
6
57
M
Muscular
18
P.I. VSD 24
+
−
+
730
7
78
F
Muscular
18
VSD 24
+
Residual shunting
−
9
8
62
F
Apical
14
VSD 16
+
−
+
49
9
77
F
Muscular
9
VSD 14
+
−
+
185
10
58
M
Muscular
15
VSD 20
+
Residual shunting
+
90
11
57
F
Muscular
28
VSD 30
−
Dislocation of device into RV
−
3
12
58
M
Muscular
10
VSD 22
+
−
+
78
13
67
M
Muscular
10
VSD 24
+
Residual shunting
+
560
14
60
M
Apical
15
−
−
LV rupture during device implantation
−
0
15
70
F
Muscular
14
VSD 20
+
−
+
1174
RV: right ventricle; LV: left ventricle; M: male; F: female; VSD: ventricular septal defect; PI: postinfarction. Follow-up duration indicates days to last contact if alive or time to death.
